insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

AHR · American Healthcare REIT, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · AHR

1YMax
Sign in to download
AnnualQuarterly

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$2.09B$1.88B$1.67B$1.41B$1.12B$67.79M
Cost of Revenue$1.79B$1.65B$1.50B$1.28B$1.03B$60.22M
Gross Profit$300.98M$229.91M$166.43M$130.63M$93.74M$7.57M
R&D------
SG&A$58.73M$47.56M$47.51M$43.42M$43.20M$16.69M
Total Operating Expenses$2.10B$1.94B$1.80B$1.56B$1.26B$150.51M
D&A$187.56M$179.19M$182.60M$167.96M$133.19M$50.30M
Operating Income$415.16M$363.54M$306.83M$301.96M$218.28M($18.94M)
Interest Expense$85.78M$127.73M$163.19M$105.96M$80.94M$19.95M
Income Tax($22.17M)$1.71M$663.0K$586.0K$956.0K$0
Net Income$69.81M($37.81M)($71.47M)($81.30M)($47.79M)($18.06M)
EPS - Basic$0.42($0.29)($1.08)($1.24)$0.01-
EPS - Diluted$0.42($0.29)($1.08)($1.24)$0.01-

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$114.84M$76.70M$43.45M$65.05M$81.60M$17.41M
Accounts Receivable------
Inventory$18.84M$19.48M$19.47M$19.77M$24.67M-
Accounts Payable------
Current Assets------
Total Assets$5.43B$4.49B$4.58B$4.79B$4.58B$1.09B
Current Liabilities------
Long-term Debt------
Total Liabilities$2.07B$2.18B$3.12B$3.14B$2.75B$540.42M
Stockholders' Equity$3.32B$2.26B$1.27B$1.40B$1.58B$548.96M
Retained Earnings($1.56B)($1.46B)($1.28B)($1.14B)($951.30M)($185.05M)

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$294.44M$176.09M$98.53M$147.77M$17.91M$35.49M
Investing Cash Flow($1.08B)($8.73M)$9.40M($118.58M)($138.65M)($76.46M)
Financing Cash Flow$817.24M($134.74M)($129.06M)($42.92M)$94.11M$43.24M
CapEx------
Free Cash Flow------

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin14.4%12.2%10.0%9.3%8.3%11.2%
Operating margin19.8%19.3%18.4%21.4%19.4%-27.9%
EBITDA margin28.8%28.8%29.3%33.3%31.3%46.3%
Net margin3.3%-2.0%-4.3%-5.8%-4.3%-26.6%
Free cash flow margin------
FCF / Net income------
R&D / Revenue------
SG&A / Revenue2.8%2.5%2.8%3.1%3.8%24.6%
Effective tax rate-46.5%-----
Return on assets1.3%-0.8%-1.6%-1.7%-1.0%-1.7%
Return on equity2.1%-1.7%-5.6%-5.8%-3.0%-3.3%
Return on invested capital------
Liquidity
Current ratio------
Quick ratio------
Cash ratio------
Leverage
Debt / Equity------
Debt / Assets------
Debt / EBITDA------
Interest coverage4.8x2.8x1.9x2.8x2.7x-0.9x
Equity multiplier1.631.983.603.422.901.99
Liabilities / Assets0.380.490.680.660.600.49
Efficiency
Asset turnover0.390.420.360.300.250.06
Inventory turnover95.2184.9277.1564.8141.76-
Days sales outstanding------
Days inventory outstanding4d4d5d6d9d-
Days payable outstanding------
Cash conversion cycle------
Valuation
P / E112.0x-----
P / B2.4x1.6x----
P / S3.7x2.0x----
EV / EBITDA12.8x6.7x----
Growth
Revenue growth (YoY)11.2%12.9%18.2%25.6%1557.9%-43.9%
Revenue CAGR (3y)14.0%18.8%190.9%127.0%137.0%45.9%
Revenue CAGR (5y)98.6%73.2%81.6%130.2%246.3%-
Gross profit growth (YoY)30.9%38.1%27.4%39.4%1138.5%-92.5%
Operating income growth (YoY)14.2%18.5%1.6%38.3%--0.4%
Net income growth (YoY)-47.1%12.1%-70.1%-164.7%3.8%
EPS growth (YoY)-73.1%12.9%---
EPS CAGR (3y)------
EPS CAGR (5y)------
FCF growth (YoY)------
FCF CAGR (5y)------
Book value growth (YoY)46.9%78.0%-9.3%-11.5%188.1%-7.0%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$2.26B total
Integrated Senior Health Campuses$1.76B · 78.0%
SHOP$330.57M · 14.6%
Outpatient Medical$126.08M · 5.6%
Triple Net Leased Properties$39.54M · 1.7%

Product / service

$1.46B total
Resident Feesand Services$1.46B · 100.0%

Geographic

$2.26B total
US$2.25B · 99.7%
Non Us$6.51M · 0.3%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

5/9
Neutral
  • ✓Net income positive
  • ✓Operating cash flow positive
  • ✓ROA improved YoY
  • ✓Cash flow > net income
  • -Long-term debt decreased
  • -Current ratio improved
  • ✗No share dilution
  • ✓Gross margin improved
  • ✗Asset turnover improved

Peer comparison

Same SIC group: Real Estate Investment Trusts

CompanyRevenue (last FY)Net marginROE
UMH$261.75M2.3%0.7%
ARE---9.2%
VTR$5.83B4.3%2.0%
SPG$6.36B72.7%88.8%
NYSE: KRC$1.11B0.0%0.0%

Comparing American Healthcare REIT against the 5 most active filers in the same SIC group.

Dividends

$1.00/share trailing 12 months · 0.0% YoY

Ex-datePer share
Mar 31, 2026$0.2500
Dec 31, 2025$0.2500
Sep 30, 2025$0.2500
Jun 30, 2025$0.2500
Mar 31, 2025$0.2500
Dec 31, 2024$0.2500
Sep 20, 2024$0.2500
Jun 27, 2024$0.2500
Mar 27, 2024$0.2500